CN Stock MarketDetailed Quotes

300519 Zhejiang Xinguang Pharmaceutical

Watchlist

14.01
-0.42-2.91%

Trading Nov 18 14:53 CST

2.24BMarket Cap51.70P/E (TTM)

Zhejiang Xinguang Pharmaceutical Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q9)Sep 30, 2024

(Q6)Jun 30, 2024

(Q3)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

(Q3)Mar 31, 2023

(FY)Dec 31, 2022

(Q9)Sep 30, 2022

(Q6)Jun 30, 2022

Operating Cash Flow

Goods sale service render cash

-5.10%206.77M

-10.56%144.8M

-2.77%104.2M

-18.13%277.68M

-13.78%217.87M

-5.25%161.9M

-3.53%107.17M

10.34%339.18M

9.22%252.68M

9.35%170.88M

Cash received relating to other operating activities

-60.24%5.84M

20.91%4.58M

69.02%2.35M

86.23%20.8M

48.73%14.69M

-57.74%3.79M

-79.12%1.39M

-44.27%11.17M

32.77%9.88M

88.38%8.96M

Cash inflows from operating activities

-8.58%212.61M

-9.85%149.37M

-1.85%106.55M

-14.80%298.49M

-11.42%232.56M

-7.87%165.69M

-7.80%108.56M

6.99%350.36M

9.95%262.56M

11.68%179.84M

Goods services cash paid

15.27%112.8M

12.78%73.1M

5.43%34.47M

18.91%132.45M

11.69%97.85M

11.47%64.82M

16.30%32.69M

67.74%111.38M

80.99%87.61M

77.72%58.15M

Staff behalf paid

-6.51%24.56M

-8.41%17.3M

-10.49%10.58M

-3.18%34.96M

-1.14%26.27M

-1.99%18.89M

-1.89%11.81M

4.61%36.11M

2.92%26.57M

6.33%19.27M

All taxes paid

-55.75%17.31M

-53.88%16.42M

-48.94%13.21M

24.73%44.9M

67.37%39.12M

181.10%35.6M

245.84%25.88M

-19.58%36M

-33.41%23.38M

-51.25%12.66M

Cash paid relating to other operating activities

-18.15%22.56M

-10.21%15.43M

-7.19%9.42M

-18.66%32.89M

-12.42%27.57M

-13.07%17.18M

-5.55%10.15M

2.59%40.44M

6.75%31.48M

0.73%19.77M

Cash outflows from operating activities

-7.12%177.23M

-10.44%122.25M

-15.96%67.68M

9.50%245.2M

12.88%190.81M

24.25%136.49M

37.95%80.53M

20.98%223.93M

21.77%169.04M

13.90%109.85M

Net cash flows from operating activities

-15.25%35.38M

-7.08%27.13M

38.69%38.87M

-57.85%53.29M

-55.36%41.75M

-58.28%29.19M

-52.79%28.03M

-11.19%126.43M

-6.46%93.52M

8.37%69.98M

Investing cash flow

Cash received from returns on investments

13.75%3.81M

23.04%2.62M

109.15%1.16M

-5.65%4.29M

4.08%3.35M

-18.50%2.13M

-13.19%555.37K

-32.87%4.55M

-39.59%3.22M

61.96%2.61M

Net cash received from disposal of fix assets、 intangible assets 、other long-term asset

400.00%100K

1,045.71%320.8K

--20K

-86.00%28K

----

Cash received relating to other investing activities

-2.53%385M

-17.24%240M

10.53%105M

9.52%460M

25.40%395M

11.54%290M

-5.00%95M

12.00%420M

40.00%315M

92.59%260M

Cash inflows from investing activities

-2.37%388.91M

-16.92%242.72M

11.18%106.26M

9.43%464.61M

25.19%398.37M

11.25%292.15M

-5.03%95.58M

10.23%424.58M

37.12%318.22M

92.16%262.61M

Cash paid to acquire fixed assets intangible assets and other long-term assets

-41.31%4.63M

84.16%4.24M

90.16%3.24M

-3.95%15.99M

-46.74%7.88M

-83.36%2.3M

-82.22%1.7M

13.13%16.64M

15.84%14.8M

29.01%13.84M

Cash paid relating to other investing activities

28.38%475M

-12.70%275M

-25.00%90M

21.95%500M

25.42%370M

31.25%315M

-11.11%120M

-1.20%410M

13.46%295M

26.32%240M

Cash outflows from investing activities

26.92%479.63M

-12.00%279.24M

-23.39%93.24M

20.94%515.99M

21.98%377.88M

25.00%317.3M

-15.82%121.7M

-0.71%426.64M

13.57%309.8M

26.46%253.84M

Net cash flows from investing activities

-542.80%-90.72M

-45.19%-36.52M

149.86%13.03M

-2,384.96%-51.37M

143.37%20.49M

-386.63%-25.15M

40.52%-26.13M

95.36%-2.07M

120.68%8.42M

113.70%8.77M

Financing cash flow

Cash received relating to other financing activities

0.00%1M

----

0.00%1M

----

0.00%1M

Cash inflows from financing activities

0.00%1M

----

0.00%1M

----

0.00%1M

Dividend interest payment

-20.00%64M

----

-16.67%80M

----

0.00%96M

Cash payments relating to other financing activities

0.00%1M

----

0.00%1M

----

0.00%1M

Cash outflows from financing activities

-19.75%65M

----

-16.49%81M

----

0.00%97M

Net cash flows from financing activities

20.00%-64M

----

16.67%-80M

----

0.00%-96M

Net cash flow

Net increase in cash and cash equivalents

-571.75%-119.33M

3.38%-73.39M

2,628.88%51.9M

-375.31%-78.08M

-399.15%-17.76M

-340.53%-75.96M

-87.68%1.9M

1,458.34%28.36M

116.17%5.94M

81.94%-17.24M

Add:Begin period cash and cash equivalents

-12.55%543.95M

4.78%622.03M

0.31%593.67M

End period cash equivalent

-29.73%424.61M

-13.83%470.55M

-4.50%595.84M

-12.55%543.95M

0.78%604.27M

-5.27%546.07M

2.43%623.93M

4.78%622.03M

8.01%599.61M

16.13%576.43M

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified opinion

Auditor

Tianjian Certified Public Accountants (Special General Partnership)

	(Q9)Sep 30, 2024	(Q6)Jun 30, 2024	(Q3)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023	(Q3)Mar 31, 2023	(FY)Dec 31, 2022	(Q9)Sep 30, 2022	(Q6)Jun 30, 2022
Operating Cash Flow
Goods sale service render cash	-5.10%206.77M	-10.56%144.8M	-2.77%104.2M	-18.13%277.68M	-13.78%217.87M	-5.25%161.9M	-3.53%107.17M	10.34%339.18M	9.22%252.68M	9.35%170.88M
Cash received relating to other operating activities	-60.24%5.84M	20.91%4.58M	69.02%2.35M	86.23%20.8M	48.73%14.69M	-57.74%3.79M	-79.12%1.39M	-44.27%11.17M	32.77%9.88M	88.38%8.96M
Cash inflows from operating activities	-8.58%212.61M	-9.85%149.37M	-1.85%106.55M	-14.80%298.49M	-11.42%232.56M	-7.87%165.69M	-7.80%108.56M	6.99%350.36M	9.95%262.56M	11.68%179.84M
Goods services cash paid	15.27%112.8M	12.78%73.1M	5.43%34.47M	18.91%132.45M	11.69%97.85M	11.47%64.82M	16.30%32.69M	67.74%111.38M	80.99%87.61M	77.72%58.15M
Staff behalf paid	-6.51%24.56M	-8.41%17.3M	-10.49%10.58M	-3.18%34.96M	-1.14%26.27M	-1.99%18.89M	-1.89%11.81M	4.61%36.11M	2.92%26.57M	6.33%19.27M
All taxes paid	-55.75%17.31M	-53.88%16.42M	-48.94%13.21M	24.73%44.9M	67.37%39.12M	181.10%35.6M	245.84%25.88M	-19.58%36M	-33.41%23.38M	-51.25%12.66M
Cash paid relating to other operating activities	-18.15%22.56M	-10.21%15.43M	-7.19%9.42M	-18.66%32.89M	-12.42%27.57M	-13.07%17.18M	-5.55%10.15M	2.59%40.44M	6.75%31.48M	0.73%19.77M
Cash outflows from operating activities	-7.12%177.23M	-10.44%122.25M	-15.96%67.68M	9.50%245.2M	12.88%190.81M	24.25%136.49M	37.95%80.53M	20.98%223.93M	21.77%169.04M	13.90%109.85M
Net cash flows from operating activities	-15.25%35.38M	-7.08%27.13M	38.69%38.87M	-57.85%53.29M	-55.36%41.75M	-58.28%29.19M	-52.79%28.03M	-11.19%126.43M	-6.46%93.52M	8.37%69.98M
Investing cash flow
Cash received from returns on investments	13.75%3.81M	23.04%2.62M	109.15%1.16M	-5.65%4.29M	4.08%3.35M	-18.50%2.13M	-13.19%555.37K	-32.87%4.55M	-39.59%3.22M	61.96%2.61M
Net cash received from disposal of fix assets、 intangible assets 、other long-term asset	400.00%100K	400.00%100K	400.00%100K	1,045.71%320.8K	--20K	--20K	--20K	-86.00%28K	----	----
Cash received relating to other investing activities	-2.53%385M	-17.24%240M	10.53%105M	9.52%460M	25.40%395M	11.54%290M	-5.00%95M	12.00%420M	40.00%315M	92.59%260M
Cash inflows from investing activities	-2.37%388.91M	-16.92%242.72M	11.18%106.26M	9.43%464.61M	25.19%398.37M	11.25%292.15M	-5.03%95.58M	10.23%424.58M	37.12%318.22M	92.16%262.61M
Cash paid to acquire fixed assets intangible assets and other long-term assets	-41.31%4.63M	84.16%4.24M	90.16%3.24M	-3.95%15.99M	-46.74%7.88M	-83.36%2.3M	-82.22%1.7M	13.13%16.64M	15.84%14.8M	29.01%13.84M
Cash paid relating to other investing activities	28.38%475M	-12.70%275M	-25.00%90M	21.95%500M	25.42%370M	31.25%315M	-11.11%120M	-1.20%410M	13.46%295M	26.32%240M
Cash outflows from investing activities	26.92%479.63M	-12.00%279.24M	-23.39%93.24M	20.94%515.99M	21.98%377.88M	25.00%317.3M	-15.82%121.7M	-0.71%426.64M	13.57%309.8M	26.46%253.84M
Net cash flows from investing activities	-542.80%-90.72M	-45.19%-36.52M	149.86%13.03M	-2,384.96%-51.37M	143.37%20.49M	-386.63%-25.15M	40.52%-26.13M	95.36%-2.07M	120.68%8.42M	113.70%8.77M
Financing cash flow
Cash received relating to other financing activities	0.00%1M	0.00%1M	----	0.00%1M	0.00%1M	0.00%1M	----	0.00%1M	0.00%1M	0.00%1M
Cash inflows from financing activities	0.00%1M	0.00%1M	----	0.00%1M	0.00%1M	0.00%1M	----	0.00%1M	0.00%1M	0.00%1M
Dividend interest payment	-20.00%64M	-20.00%64M	----	-16.67%80M	-16.67%80M	-16.67%80M	----	0.00%96M	0.00%96M	0.00%96M
Cash payments relating to other financing activities	0.00%1M	0.00%1M	----	0.00%1M	0.00%1M	0.00%1M	----	0.00%1M	0.00%1M	0.00%1M
Cash outflows from financing activities	-19.75%65M	-19.75%65M	----	-16.49%81M	-16.49%81M	-16.49%81M	----	0.00%97M	0.00%97M	0.00%97M
Net cash flows from financing activities	20.00%-64M	20.00%-64M	----	16.67%-80M	16.67%-80M	16.67%-80M	----	0.00%-96M	0.00%-96M	0.00%-96M
Net cash flow
Net increase in cash and cash equivalents	-571.75%-119.33M	3.38%-73.39M	2,628.88%51.9M	-375.31%-78.08M	-399.15%-17.76M	-340.53%-75.96M	-87.68%1.9M	1,458.34%28.36M	116.17%5.94M	81.94%-17.24M
Add:Begin period cash and cash equivalents	-12.55%543.95M	-12.55%543.95M	-12.55%543.95M	4.78%622.03M	4.78%622.03M	4.78%622.03M	4.78%622.03M	0.31%593.67M	0.31%593.67M	0.31%593.67M
End period cash equivalent	-29.73%424.61M	-13.83%470.55M	-4.50%595.84M	-12.55%543.95M	0.78%604.27M	-5.27%546.07M	2.43%623.93M	4.78%622.03M	8.01%599.61M	16.13%576.43M
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	--	--	Unqualified opinion	--	--	--	Unqualified opinion	--	--
Auditor	--	--	--	Tianjian Certified Public Accountants (Special General Partnership)	--	--	--	Tianjian Certified Public Accountants (Special General Partnership)	--	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

300519 Zhejiang Xinguang Pharmaceutical

Zhejiang Xinguang Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Analysis

Analyst Rating

Price Target